Interferon Alfa plus Chemotherapy for Non-Hodgkin's Lymphoma: Five-Year Follow-up: Letter

To the Editor: As we previously reported (November 5, 1992, issue),1 interferon alfa, when added to a four-drug, doxorubicin-based chemotherapy regimen, is an effective antitumor agent in patients with clinically aggressive low-grade or intermediate-grade non-Hodgkin's lymphoma. [...]interferon...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 1993-12, Vol.329 (24), p.1821
Hauptverfasser:	Andersen, Janet W, Smalley, Richard V
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemotherapy Health risk assessment Hodgkin's lymphoma Interferon Lymphoma Non-Hodgkin's lymphoma α-Interferon
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To the Editor: As we previously reported (November 5, 1992, issue),1 interferon alfa, when added to a four-drug, doxorubicin-based chemotherapy regimen, is an effective antitumor agent in patients with clinically aggressive low-grade or intermediate-grade non-Hodgkin's lymphoma. [...]interferon added to induction chemotherapy for patients with low-grade or intermediate-grade non-Hodgkin's lymphoma prolongs the time to treatment failure, but its effect on overall survival, if any, is not significant.
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJM199312093292419